This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Goplen, D. Articles by Bjerkvig, R. Search for Related Content PubMed PubMed Citation Articles by Goplen, D. Articles by Bjerkvig, R.

Protein Disulfide Isomerase Expression Is Related to the Invasive Properties of Malignant Glioma

¹ Department of Biomedicine, University of Bergen; ² The Gade Institute, University of Bergen, Haukeland University Hospital, Bergen, Norway; and ³ NorLux Neuro-Oncology, Centre Recherche Public de la Santé, Luxembourg

Requests for reprints: Dorota Goplen, The Gade Institute, University of Bergen, Haukeland University Hospital, N-5021 Bergen, Norway. Phone: 475-597-2616; E-mail: dorota.goplen{at}biomed.uib.no.

By serial transplantation of human glioblastoma biopsies into the brain of immunodeficient nude rats, two different tumor phenotypes were obtained. Initially, the transplanted xenografts displayed a highly invasive phenotype that showed no signs of angiogenesis. By serial transplantation in animals, the tumors changed to a less invasive, predominantly angiogenic phenotype. To identify novel proteins related to the invasive phenotype, the xenografts were analyzed using a global proteomics approach. One of the identified proteins was protein disulfide isomerase (PDI) A6 precursor. PDI is a chaperone protein that mediates integrin-dependent cell adhesion. It is both present in the cytosol and at the cell surface. We show that PDI is strongly expressed on invasive glioma cells, in both xenografts and at the invasive front of human glioblastomas. Using an in vitro migration assay, we also show that PDI is expressed on migrating glioma cells. To determine the functional significance of PDI in cell migration, we tested the effect of a PDI inhibitor, bacitracin, and a PDI monoclonal antibody on glioma cell migration and invasion in vitro. Both tumor spheroids derived from human glioblastoma xenografts in nude rat brain and cell line spheroids were used. The PDI antibody, as well as bacitracin, inhibited tumor cell migration and invasion. The anti-invasive effect of bacitracin was reversible after withdrawal of the inhibitor, indicating a specific, nontoxic effect. In conclusion, using a global proteomics approach, PDI was identified to play an important role in glioma cell invasion, and its action was effectively inhibited by bacitracin. (Cancer Res 2006; 66(20): 9895-902)

This article has been cited by other articles:

				P. E. Lovat, M. Corazzari, J. L. Armstrong, S. Martin, V. Pagliarini, D. Hill, A. M. Brown, M. Piacentini, M. A. Birch-Machin, and C. P.F. Redfern Increasing Melanoma Cell Death Using Inhibitors of Protein Disulfide Isomerases to Abrogate Survival Responses to Endoplasmic Reticulum Stress Cancer Res., July 1, 2008; 68(13): 5363 - 5369. [Abstract] [Full Text] [PDF]

				D. M. Townsend, L. He, S. Hutchens, T. E. Garrett, C. J. Pazoles, and K. D. Tew NOV-002, a Glutathione Disulfide Mimetic, as a Modulator of Cellular Redox Balance Cancer Res., April 15, 2008; 68(8): 2870 - 2877. [Abstract] [Full Text] [PDF]

				P. C. Huszthy, D. Goplen, F. Thorsen, H. Immervoll, J. Wang, A. Gutermann, H. Miletic, and R. Bjerkvig Oncolytic Herpes Simplex Virus Type-1 Therapy in a Highly Infiltrative Animal Model of Human Glioblastoma Clin. Cancer Res., March 1, 2008; 14(5): 1571 - 1580. [Abstract] [Full Text] [PDF]

				Y. Wang, Y. Ma, B. Lu, E. Xu, Q. Huang, and M. Lai Differential Expression of Mimecan and Thioredoxin Domain Containing Protein 5 in Colorectal Adenoma and Cancer: A Proteomic Study Experimental Biology and Medicine, October 1, 2007; 232(9): 1152 - 1159. [Abstract] [Full Text] [PDF]